Immune privilege (IP), a term introduced to explain the unpredicted acceptance of allogeneic grafts by the eye and the brain, is considered a unique property of these tissues. However, immune responses are modified by the tissue in which they occur, most of which possess IP to some degree. The eye therefore displays a spectrum of IP because it comprises several tissues. IP as originally conceived can only apply to the retina as it contains few tissue-resident bone-marrow derived myeloid cells and is immunologically shielded by a sophisticated barrier - an inner vascular and an outer epithelial barrier at the retinal pigment epithelium. The vascular barrier comprises the vascular endothelium and the glia limitans. Immune cells do not cross the blood-retinal barrier (BRB) despite two-way transport of interstitial fluid, governed by tissue oncotic pressure. The BRB, and the blood-brain barrier (BBB) mature in the neonatal period under signals from the expanding microbiome and by 18 months are fully established. However, the adult eye is susceptible to intraocular inflammation (uveitis; frequency ~200/100,000 population). Uveitis involving the retinal parenchyma (posterior uveitis, PU) breaches IP, while IP is essentially irrelevant in inflammation involving the ocular chambers, uveal tract and ocular coats (anterior/intermediate uveitis/sclerouveitis, AU). Infections cause ~50% cases of AU and PU but infection may also underlie the pathogenesis of immune-mediated "non-infectious" uveitis. Dysbiosis accompanies the commonest form, HLA-B27-associated AU, while latent infections underlie BRB breakdown in PU. This review considers the pathogenesis of uveitis in the context of IP, infection, environment, and the microbiome.

Department of Ophthalmology 1st Faculty of Medicine Charles University and General University Hospital Prague Prague Czechia

Eye Clinic Aberdeen Royal Infirmary Aberdeen United Kingdom

Institute of Medical Sciences University of Aberdeen Aberdeen United Kingdom

Zobrazit více v PubMed

Forrester JV, Xu H. Good news-bad news: the Yin and Yang of immune privilege in the eye. Front Immunol (2012) 3:338. 10.3389/fimmu.2012.00338 PubMed DOI PMC

Matzinger P, Kamala T. Tissue-based class control: the other side of tolerance. Nat Rev Immunol (2011) 11(3):221–30. 10.1038/nri2940 PubMed DOI

Forrester JV. Ebola virus and persistent chronic infection: when does replication cease? Ann Trans Med (2018) 6(Suppl 1):S39. 10.21037/atm.2018.09.60 PubMed DOI PMC

Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukocyte Biol (2003) 74(2):179–85. 10.1189/jlb.1102574 PubMed DOI

Caspi RR. Ocular autoimmunity: the price of privilege? Immunol Rev (2006) 213:23–35. 10.1111/j.1600-065X.2006.00439.x PubMed DOI

Hazlett LD, Hendricks RL. Reviews for Immune Privilege in the Year 2010: Immune Privilege and Infection. Ocular Immunol Inflammation (2010) 18(4):237–43. 10.3109/09273948.2010.501946 PubMed DOI

Stein-Streilein J. Mechanisms of immune privilege in the posterior eye. Int Rev Immunol (2013) 32(1):42–56. 10.3109/08830185.2012.740535 PubMed DOI

Dick AD. Doyne lecture 2016: intraocular health and the many faces of inflammation. Eye (2017) 31(1):87–96. 10.1038/eye.2016.177 PubMed DOI PMC

Gery I, Caspi RR. Tolerance Induction in Relation to the Eye. Front Immunol (2018) 9:2304. 10.3389/fimmu.2018.02304 PubMed DOI PMC

Williams KA, Esterman AJ, Bartlett C, Holland H, Hornsby NB, Coster DJ. How effective is penetrating corneal transplantation? Factors influencing long-term outcome in multivariate analysis. Transplantation (2006) 81(6):896–901. 10.1097/01.tp.0000185197.37824.35 PubMed DOI

Forrester JV, McMenamin PG, Dando SJ. CNS infection and immune privilege. Nat Rev Neurosci (2018) 19(11):655–71. 10.1038/s41583-018-0070-8 PubMed DOI

Jabs DA. Epidemiology of uveitis. Ophthalmic Epidemiol (2008) 15(5):283–4. 10.1080/09286580802478724 PubMed DOI

Braniste V, Al-Asmakh M, Kowal C, Anuar F, Abbaspour A, Tóth M, et al. The gut microbiota influences blood-brain barrier permeability in mice. Sci Trans Med (2014) 6(263):263ra158–263ra158. 10.1126/scitranslmed.3009759 PubMed DOI PMC

Bhattarai Y. Microbiota-gut-brain axis: Interaction of gut microbes and their metabolites with host epithelial barriers. Neurogastroenterol Motil (2018) 30(6):e13366. 10.1111/nmo.13366 PubMed DOI

Michel L, Prat A. One more role for the gut: microbiota and blood brain barrier. Ann Trans Med (2016) 4(1):15–5. 10.3978/j.issn.2305-5839.2015.10.16 PubMed DOI PMC

Rosenbaum JT, Asquith M. The microbiome and HLA-B27-associated acute anterior uveitis. Nat Rev Rheumatol (2018) 14(12):704–13. 10.1038/s41584-018-0097-2 PubMed DOI PMC

Niederkorn JY. Immune privilege of corneal allografts, in Cornea and External Eye Disease. Berlin, Heidelberg: Springer; (2010) p.1–12. 10.1097/00007890-199906270-00001 DOI

Medawar PB. The immunology of transplantation. Harvey Lectures (1956) (Series 52):144–76. PubMed

Medawar PB. Immunological tolerance. Science (1961) 133(3449):303–6. 10.1126/science.133.3449.303 PubMed DOI

Medawar PB. Immunity to homologous grafted skin; the fate of skin homografts transplanted to the brain, to subcutaneous tissue, and to the anterior chamber of the eye. Br J Exp Pathol (1948) 29(1):58–69. PubMed PMC

Gregerson DS, Torseth JW, McPherson SW, Roberts JP, Shinohara T, Zack DJ. Retinal expression of a neo-self antigen, beta-galactosidase, is not tolerogenic and creates a target for autoimmune uveoretinitis. J Immunol (1999) 163(2):1073–80. PubMed

Carson MJ, Doose JM, Melchior B, Schmid CD, Ploix CC. CNS immune privilege: hiding in plain sight. Immunol Rev (2006) 213(1):48–65. 10.1111/j.1600-065X.2006.00441.x PubMed DOI PMC

Cobbold SP. Regulatory T cells and transplantation tolerance. J Nephrol (2008) 21(4):485–96. PubMed

Niederkorn JY. Corneal transplantation and immune privilege. Int Rev Immunol (2013) 32(1):57–67. 10.3109/08830185.2012.737877 PubMed DOI PMC

Louveau A, Harris TH, Kipnis J. Revisiting the mechanisms of CNS immune privilege. Trends Immunol (2015) 36(10):569–77. 10.1016/j.it.2015.08.006 PubMed DOI PMC

Engelhardt B, Vajkoczy P, Weller RO. The movers and shapers in immune privilege of the CNS. Nat Immunol (2017) 18(2):123. 10.1038/ni.3666 PubMed DOI

Wildner G, Diedrichs-Möhring M. Resolution of uveitis. Semin Immunopathol (2019) 41(6):727–36. 10.1007/s00281-019-00758-z PubMed DOI

Ferguson TA, Herndon JM. The immune response and the eye: the ACAID inducing signal is dependent on the nature of the antigen. Invest Ophthalmol Visual Sci (1994) 35(7):3085–93. PubMed

Stein-Streilein J, Streilein JW. Anterior chamber associated immune deviation (ACAID): regulation, biological relevance, and implications for therapy. Int Rev Immunol (2002) 21(2-3):123–52. 10.1080/08830180212066 PubMed DOI

Wenkel H, Streilein JW, Young MJ. Systemic Immune Deviation in the Brain That Does Not Depend on the Integrity of the Blood-Brain Barrier. J Immunol (2000) 164(10):5125. 10.4049/jimmunol.164.10.5125 PubMed DOI

Li XY, D’orazio T, Niederkorn J. Role of Th1 and Th2 cells in anterior chamber-associated immune deviation. Immunology (1996) 89(1):34–40. 10.1046/j.1365-2567.1996.d01-714.x PubMed DOI PMC

Zhang-Hoover J, Stein-Streilein J. Therapies based on principles of ocular immune privilege. Immune Response Eye (2007) 92:317–27. 10.1159/000099281 PubMed DOI

Streilein JW, Niederkorn JY. Induction of anterior chamber-associated immune deviation requires an intact, functional spleen. J Exp Med (1981) 153(5):1058–67. 10.1084/jem.153.5.1058 PubMed DOI PMC

Niederkorn JY, Streilein JW, Kripke ML. Promotion of Syngeneic Intraocular Tumor Growth in Mice by Anterior Chamber-Associated Immune Deviation. JNCI: J Natl Cancer Institute (1983) 71(1):193–9. 10.1093/jnci/71.1.193 PubMed DOI

Dang Z, Kuffova L, Liu L, Forrester JV. Soluble antigen traffics rapidly and selectively from the corneal surface to the eye draining lymph node and activates T cells when codelivered with CpG oligonucleotides. J Leukocyte Biol (2014) 95(3):431–40. 10.1189/jlb.0612294 PubMed DOI

Kuffová L, Lumsden L, Veselá V, Taylor JA, Filipec M, Holán V, et al. Kinetics of leukocyte and myeloid cell traffic in the murine corneal allograft response. Transplantation (2001) 72(7):1292–8. 10.1097/00007890-200110150-00019 PubMed DOI

Kuffová L, Netuková M, Duncan L, Porter A, Stockinger B, Forrester JV. Cross Presentation of Antigen on MHC Class II via the Draining Lymph Node after Corneal Transplantation in Mice. J Immunol (2008) 180(3):1353. 10.4049/jimmunol.180.3.1353 PubMed DOI

Plsková J, Duncan L, Holán V, Filipec M, Kraal G, Forrester JV. The immune response to corneal allograft requires a site-specific draining lymph node. Transplantation (2002) 73(2):210–5. 10.1097/00007890-200201270-00010 PubMed DOI

Gregerson DS. Immune privilege in the retina. Ocular Immunol Inflammation (1998) 6(4):257–67. 10.1076/ocii.6.4.257.4029 PubMed DOI

Harris MG, Hulseberg P, Ling C, Karman J, Clarkson BD, Harding JS, et al. Immune privilege of the CNS is not the consequence of limited antigen sampling. Sci Rep (2014) 4:4422. 10.1038/srep04422 PubMed DOI PMC

Voigt V, Wikstrom ME, Kezic JM, Schuster IS, Fleming P, Makinen K, et al. Ocular antigen does not cause disease unless presented in the context of inflammation. Sci Rep (2017) 7(1):14226. 10.1038/s41598-017-14618-z PubMed DOI PMC

Keino H, Sugita S. Immune Privilege and Eye-Derived T-Regulatory Cells. J Immunol Res (2018) 2018:1679197. 10.1155/2018/1679197 PubMed DOI PMC

McPherson SW, Heuss ND, Gregerson DS. Local “on-demand” generation and function of antigen-specific Foxp3+ regulatory T cells. J Immunol (2013) 190(10):4971–81. 10.4049/jimmunol.1202625 PubMed DOI PMC

McPherson SW, Heuss ND, Pierson MJ, Gregerson DS. Retinal antigen-specific regulatory T cells protect against spontaneous and induced autoimmunity and require local dendritic cells. J Neuroinflamm (2014) 11:205. 10.1186/s12974-014-0205-4 PubMed DOI PMC

Engelhardt B, Carare RO, Bechmann I, Flügel A, Laman JD, Weller RO. Vascular, glial, and lymphatic immune gateways of the central nervous system. Acta Neuropathol (2016) 132(3):317–38. 10.1007/s00401-016-1606-5 PubMed DOI PMC

Forrester JV, Xu H, Kuffova L, Dick AD, McMenamin PG. Dendritic cell physiology and function in the eye. Immunol Rev (2010) 234(1):282–304. 10.1111/j.0105-2896.2009.00873.x PubMed DOI

Dua H, McKinnon A, McMenamin P, Forrester J. Ultrastructural pathology of the’barrier sites’ in experimental autoimmune uveitis and experimental autoimmune pinealitis. Br J Ophthalmol (1991) 75(7):391–7. 10.1136/bjo.75.7.391 PubMed DOI PMC

Xu H, Koch P, Chen M, Lau A, Reid DM, Forrester JV. A clinical grading system for retinal inflammation in the chronic model of experimental autoimmune uveoretinitis using digital fundus images. Exp Eye Res (2008) 87(4):319–26. 10.1016/j.exer.2008.06.012 PubMed DOI

McMenamin P, Forrester J, Steptoe R, Dua H. Ultrastructural pathology of experimental autoimmune uveitis. Quantitative evidence of activation and possible high endothelial venule-like changes in retinal vascular endothelium. Lab Invest J Tech Methods Pathol (1992) 67(1):42–55. PubMed

Mattapallil MJ, Silver PB, Mattapallil JJ, Horai R, Karabekian Z, McDowell JH, et al. Uveitis-associated epitopes of retinal antigens are pathogenic in the humanized mouse model of uveitis and identify autoaggressive T cells. J Immunol (Baltimore Md: 1950) (2011) 187(4):1977–85. 10.4049/jimmunol.1101247 PubMed DOI PMC

Caspi RR. Immunogenetic aspects of clinical and experimental uveitis. Regional Immunol (1992) 4(5):321–30. PubMed

Atan D, Heissigerova J, Kuffová L, Hogan A, Kilmartin DJ, Forrester JV, et al. Tumor necrosis factor polymorphisms associated with tumor necrosis factor production influence the risk of idiopathic intermediate uveitis. Mol Vision (2013) 19:184. PubMed PMC

Kilmartin DJ, Wilson D, Liversidge J, Dick AD, Bruce J, Acheson RW, et al. Immunogenetics and clinical phenotype of sympathetic ophthalmia in British and Irish patients. Br J Ophthalmol (2001) 85(3):281–6. 10.1136/bjo.85.3.281 PubMed DOI PMC

Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity (2017) 46(4):562–76. 10.1016/j.immuni.2017.04.008 PubMed DOI PMC

Belkaid Y, Tamoutounour S. The influence of skin microorganisms on cutaneous immunity. Nat Rev Immunol (2016) 16(6):353–66. 10.1038/nri.2016.48 PubMed DOI

Berlinberg A, Kuhn KA. Barrier lymphocytes in spondyloarthritis. Curr Opin Rheumatol (2020) 32(4):343–48. 10.1097/BOR.0000000000000716 PubMed DOI PMC

Taylor AW, Ng TF. Negative regulators that mediate ocular immune privilege. J Leukocyte Biol (2018) 103(6):1179–87. 10.1002/JLB.3MIR0817-337R PubMed DOI PMC

van den Berg TK. On the origin and function of immune ‘self’recognition. Immunol Lett (2010) 1(128):24–5. 10.1016/j.imlet.2009.09.013 PubMed DOI

Lucca LE, Dominguez-Villar M. Modulation of regulatory T cell function and stability by co-inhibitory receptors. Nat Rev Immunol (2020) p:1–14. 10.1038/s41577-020-0296-3 PubMed DOI

Spadoni I, Fornasa G, Rescigno M. Organ-specific protection mediated by cooperation between vascular and epithelial barriers. Nat Rev Immunol (2017) 17(12):761. 10.1038/nri.2017.100 PubMed DOI

Priyadarshini M, Kotlo KU, Dudeja PK, Layden BT. Role of short chain fatty acid receptors in intestinal physiology and pathophysiology. Compr Physiol (2011) 8(3):1091–115. 10.1002/cphy.c170050 PubMed DOI PMC

Amabebe E, Robert FO, Agbalalah T, Orubu ESF. Microbial dysbiosis-induced obesity: role of gut microbiota in homoeostasis of energy metabolism. Br J Nutr (2020) 123(10):1127–37. 10.1017/S0007114520000380 PubMed DOI

Engevik MA, Morra CN, Röth D, Engevik K, Spinler JK, Devaraj S, et al. Microbial Metabolic Capacity for Intestinal Folate Production and Modulation of Host Folate Receptors. Front Microbiol (2019) 10:2305–5. 10.3389/fmicb.2019.02305 PubMed DOI PMC

Fukuda S, Toh H, Hase K, Oshima K, Nakanishi Y, Yoshimura K, et al. Bifidobacteria can protect from enteropathogenic infection through production of acetate. Nature (2011) 469(7331):543–7. 10.1038/nature09646 PubMed DOI

Kinoshita M, Kayama H, Kusu T, Yamaguchi T, Kunisawa J, Kiyono H, et al. Dietary Folic Acid Promotes Survival of Foxp3+ Regulatory T Cells in the Colon. J Immunol (2012) 189(6):2869. 10.4049/jimmunol.1200420 PubMed DOI

Trujillo-Vargas CM, Schaefer L, Alam J, Pflugfelder SC, Britton RA, de Paiva CS. The gut-eye-lacrimal gland-microbiome axis in Sjögren Syndrome. Ocular Surface (2020) 18(2):335–44. 10.1016/j.jtos.2019.10.006 PubMed DOI PMC

Chun E, Lavoie S, Fonseca-Pereira D, Bae S, Michaud M, Hoveyda HR, et al. Metabolite-sensing receptor Ffar2 regulates colonic group 3 innate lymphoid cells and gut immunity. Immunity (2019) 51(5):871–884. e6. 10.1016/j.immuni.2019.09.014 PubMed DOI PMC

Forrester JV, Kuffova L, Dick AD. Autoimmunity, Autoinflammation and Infection in Uveitis. Am J Ophthalmol (2018) 189:77–85. 10.1016/j.ajo.2018.02.019 PubMed DOI

Al-Asmakh M, Hedin L. Microbiota and the control of blood-tissue barriers. Tissue Barriers (2015) 3(3):e1039691. 10.1080/21688370.2015.1039691 PubMed DOI PMC

Lu J, Lu L, Yu Y, Baranowski J, Claud EC. Maternal administration of probiotics promotes brain development and protects offspring’s brain from postnatal inflammatory insults in C57/BL6J mice. Sci Rep (2020) 10(1):1–16. 10.1038/s41598-020-65180-0 PubMed DOI PMC

Weström B, Arévalo Sureda E, Pierzynowska K, Pierzynowski SG, Pérez-Cano F-J. The Immature Gut Barrier and Its Importance in Establishing Immunity in Newborn Mammals. Front Immunol (2020) 11:1153. 10.3389/fimmu.2020.01153 PubMed DOI PMC

Michalicova A, Majerova P, Kovac A. Tau Protein and Its Role in Blood–Brain Barrier Dysfunction. Front Mol Neurosci (2020) 13:178. 10.3389/fnmol.2020.570045 PubMed DOI PMC

Yan C, Zhou Y, Chen Q, Luo Y, Zhang JH, Huang H, et al. Dysfunction of the neurovascular unit in diabetes-related neurodegeneration. Biomed Pharmacother (2020) 131:110656. 10.1016/j.biopha.2020.110656 PubMed DOI

Chen M, Luo C, Zhao J, Devarajan G, Xu H. Immune regulation in the aging retina. Prog Retinal Eye Res (2019) 69:159–72. 10.1016/j.preteyeres.2018.10.003 PubMed DOI PMC

Xu H, Chen M, Forrester JV. Para-inflammation in the aging retina. Prog Retinal Eye Res (2009) 28(5):348–68. 10.1016/j.preteyeres.2009.06.001 PubMed DOI

Jiang C, Li G, Huang P, Liu Z, Zhao B. The gut microbiota and Alzheimer’s disease. J Alzheimer’s Dis (2017) 58(1):1–15. 10.3233/JAD-161141 PubMed DOI

Jabs DA, Nussenblatt RB. J T Rosenbaum, and G Standardization of Uveitis Nomenclature Working, Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol (2005) 140(3):509–16. 10.1016/j.ajo.2005.03.057 PubMed DOI PMC

Cunningham ET, Jr., Forrester JV, Rao NA, Zierhut M. Post-infectious uveitis. Ocular Immunol Inflammation (2016) 24:603–6. 10.1080/09273948.2016.1253983 PubMed DOI

Song A, Liu X, Huang X, Meyers K, Oh D-Y, Hou J, et al. From CD4-based initiation to treating all HIV-infected adults immediately: an evidence-based meta-analysis. Front Immunol (2018) 9:212. 10.3389/fimmu.2018.00212 PubMed DOI PMC

Aldrete S, Jang JH, Easley KA, Okulicz J, Dai T, Chen YN, et al. CD4 rate of increase is preferred to CD4 threshold for predicting outcomes among virologically suppressed HIV-infected adults on antiretroviral therapy. PloS One (2020) 15(1):e0227124. 10.1371/journal.pone.0227124 PubMed DOI PMC

Sudharshan S, Nair N, Curi A, Banker A, Kempen JH. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy-An update. Indian J Ophthalmol (2020) 68(9):1787–98. 10.4103/ijo.IJO_1248_20 PubMed DOI PMC

Joao I, Bujdáková H, Jordao L. Opportunist Coinfections by Nontuberculous Mycobacteria and Fungi in Immunocompromised Patients. Antibiotics (2020) 9(11):771. 10.3390/antibiotics9110771 PubMed DOI PMC

Nizami S, Morales C, Hu K, Holzman R, Rapkiewicz A. Trends in Mortality From Human Immunodeficiency Virus Infection, 1984–2016: An Autopsy-Based Study. Arch Pathol Lab Med (2020) 144(5):572–9. 10.5858/arpa.2019-0144-OA PubMed DOI

Bowen LN, Smith B, Reich D, Quezado M, Nath A. HIV-associated opportunistic CNS infections: pathophysiology, diagnosis and treatment. Nat Rev Neurol (2016) 12(11):662. 10.1038/nrneurol.2016.149 PubMed DOI

Yasunaga J, Matsuoka M. Molecular mechanisms of HTLV-1 infection and pathogenesis. Int J Hematol (2011) 94(5):435–42. 10.1007/s12185-011-0937-1 PubMed DOI

Carmichael A. Cytomegalovirus and the eye. Eye (2012) 26(2):237–40. 10.1038/eye.2011.327 PubMed DOI PMC

Lee JH, Agarwal A, Mahendradas P, Lee CS, Gupta V, Pavesio CE, et al. Viral posterior uveitis. Survey Ophthalmol (2017) 62(4):404–45. 10.1016/j.survophthal.2016.12.008 PubMed DOI PMC

Chan NS-W, Chee S-P, Caspers L, Bodaghi B. Clinical features of CMV-associated anterior uveitis. Ocular Immunol Inflammation (2018) 26(1):107–15. 10.1080/09273948.2017.1394471 PubMed DOI

Wang H-M, Sheu M-M, Stulting RD, Kaplan HJ. Immunohistochemical evaluation of murine HSV-1 keratouveitis. Curr Eye Res (1989) 8(1):37–46. 10.3109/02713688909013892 PubMed DOI

Gineys R, Bodaghi B, Carcelain G, Cassoux N, Amoura Z, Lehoang P, et al. QuantiFERON-TB gold cut-off value: implications for the management of tuberculosis-related ocular inflammation. Am J Ophthalmol (2011) 152(3):433–440. e1. 10.1016/j.ajo.2011.02.006 PubMed DOI

Nora RLD, Van Velthoven ME, Ninette H, Misotten T, Bakker M, Van Hagen MP, et al. Clinical manifestations of patients with intraocular inflammation and positive QuantiFERON–TB Gold In-Tube Test in a country nonendemic for tuberculosis. Am J Ophthalmol (2014) 157(4):754–61. 10.1016/j.ajo.2013.11.013 PubMed DOI

Lee RW, Nicholson LB, Sen HN, Chan CC, Wei L, Nussenblatt RB, et al. Autoimmune and autoinflammatory mechanisms in uveitis. Semin Immunopathol (2014) 36(5):581–94. 10.1007/s00281-014-0433-9 PubMed DOI PMC

Nussenblatt R. Proctor Lecture. Experimental autoimmune uveitis: mechanisms of disease and clinical therapeutic indications. Invest Ophthalmol Visual Sci (1991) 32(13):3131–41. PubMed

Wacker WB, Donoso LA, Kalsow CM, Yankeelov JA, Organisciak DT. Experimental allergic uveitis. Isolation, characterization, and localization of a soluble uveitopathogenic antigen from bovine retina. J Immunol (1977) 119(6):1949–58. PubMed

Caspi RR, Chan C-C, Wiggert B, Chader GJ. The mouse as a model of experimental autoimmune uveoretinitis (EAU). Curr Eye Res (1990) 9(sup1):169–74. 10.3109/02713689008999438 PubMed DOI

Wan Q, McCormick D, Shah R, Giraldo A, David C, Kong Y. Induction of autoimmune thyroiditis by unique human thyroglobulin epitopes in H2E transgenic mice. FASEB J (1998) 12(5):A1051.

Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol (2007) 7(11):904–12. 10.1038/nri2190 PubMed DOI

Schlüter A, Flögel U, Diaz-Cano S, Görtz G-E, Stähr K, Oeverhaus M, et al. Graves’ orbitopathy occurs sex-independently in an autoimmune hyperthyroid mouse model. Sci Rep (2018) 8(1):1–13. 10.1038/s41598-018-31253-4 PubMed DOI PMC

Caspi RR. A look at autoimmunity and inflammation in the eye. J Clin Invest (2010) 120(9):3073–83. 10.1172/JCI42440 PubMed DOI PMC

Kezic JM, Glant TT, Rosenbaum JT, Rosenzweig HL. Neutralization of IL-17 ameliorates uveitis but damages photoreceptors in a murine model of spondyloarthritis. Arthritis Res Ther (2012) 14(1):R18. 10.1186/ar3697 PubMed DOI PMC

Forrester JV, Steptoe RJ, Klaska IP, Martin-Granados C, Dua HS, Degli-Esposti MA, et al. Cell-based therapies for ocular inflammation. Prog Retinal Eye Res (2013) 35:82–101. 10.1016/j.preteyeres.2013.02.002 PubMed DOI

Klaska IP, Forrester JV. Mouse models of autoimmune uveitis. Curr Pharm Design (2015) 21(18):2453–67. 10.2174/1381612821666150316122928 PubMed DOI

Fang J, Fang D, Silver PB, Wen F, Li B, Ren X, et al. The role of TLR2, TRL3, TRL4, and TRL9 signaling in the pathogenesis of autoimmune disease in a retinal autoimmunity model. Invest Ophthalmol Visual Sci (2010) 51(6):3092–9. 10.1167/iovs.09-4754 PubMed DOI PMC

Chinnery HR, Leong CM, Chen W, Forrester JV, McMenamin PG. TLR9 and TLR7/8 activation induces formation of keratic precipitates and giant macrophages in the mouse cornea. J Leukocyte Biol (2015) 97(1):103–10. 10.1189/jlb.3AB0414-216R PubMed DOI

Basu S, Rao N, Elkington P. Animal Models of Ocular Tuberculosis: Implications for Diagnosis and Treatment. Ocular Immunol Inflammation (2020) p:1–7. 10.1080/09273948.2020.1746358 PubMed DOI

Bridgewood C, Sharif K, Sherlock J, Watad A, McGonagle D. Interleukin-23 pathway at the enthesis: The emerging story of enthesitis in spondyloarthropathy. Immunol Rev (2020) 294(1):27–47. 10.1111/imr.12840 PubMed DOI

Ghasemi Y, Dabbagh F, Rasoul-Amini S, Haghighi AB, Morowvat MH, medicine The possible role of HSPs on Behçet’s disease: a bioinformatic approach. Comput Biol (2012) 42(11):1079–85. 10.1016/j.compbiomed.2012.08.009 PubMed DOI

Consolandi C, Turroni S, Emmi G, Severgnini M, Fiori J, Peano C, et al. Behçet’s syndrome patients exhibit specific microbiome signature. Autoimmun Rev (2015) 14(4):269–76. 10.1016/j.autrev.2014.11.009 PubMed DOI

Shimizu J, Kubota T, Takada E, Takai K, Fujiwara N, Arimitsu N, et al. Bifidobacteria abundance-featured gut microbiota compositional change in patients with Behcet’s disease. PloS One (2016) 11(4):e0153746. 10.1371/journal.pone.0153746 PubMed DOI PMC

Ye Z, Zhang N, Wu C, Zhang X, Wang Q, Huang X, et al. A metagenomic study of the gut microbiome in Behcet’s disease. Microbiome (2018) 6(1):135. 10.1186/s40168-018-0520-6 PubMed DOI PMC

Horai R, Silver PB, Chen J, Agarwal RK, Chong WP, Jittayasothorn Y, et al. Breakdown of immune privilege and spontaneous autoimmunity in mice expressing a transgenic T cell receptor specific for a retinal autoantigen. J Autoimmun (2013) 44:21–33. 10.1016/j.jaut.2013.06.003 PubMed DOI PMC

Horai R, Zarate-Blades CR, Dillenburg-Pilla P, Chen J, Kielczewski JL, Silver PB, et al. Microbiota-Dependent Activation of an Autoreactive T Cell Receptor Provokes Autoimmunity in an Immunologically Privileged Site. Immunity (2015) 43(2):343–53. 10.1016/j.immuni.2015.07.014 PubMed DOI PMC

Heissigerova J, Seidler Stangova P, Klimova A, Svozilkova P, Hrncir T, Stepankova R, et al. The Microbiota Determines Susceptibility to Experimental Autoimmune Uveoretinitis. J Immunol Res (2016) 2016:5065703. 10.1155/2016/5065703 PubMed DOI PMC

Horai R, Caspi RR. Microbiome and autoimmune uveitis. Front Immunol (2019) 10:232. 10.3389/fimmu.2019.00232 PubMed DOI PMC

Prendergast RA, Iliff CE, Coskuncan NM, Caspi RR, Sartani G, Tarrant TK, et al. T cell traffic and the inflammatory response in experimental autoimmune uveoretinitis. Invest Ophthalmol Visual Sci (1998) 39(5):754–62. PubMed

Xu H, Manivannan A, Goatman KA, Jiang HR, Liversidge J, Sharp PF, et al. Reduction in shear stress, activation of the endothelium, and leukocyte priming are all required for leukocyte passage across the blood—retina barrier. J Leukocyte Biol (2004) 75(2):224–32. 10.1189/jlb.1002479 PubMed DOI

Xu H, Manivannan A, Liversidge J, Sharp PF, Forrester JV, Crane IJ. Requirements for passage of T lymphocytes across non-inflamed retinal microvessels. J Neuroimmunol (2003) 142(1-2):47–57. 10.1016/S0165-5728(03)00258-3 PubMed DOI

Crane IJ, Xu H, Wallace C, Manivannan A, Mack M, Liversidge J, et al. Involvement of CCR5 in the passage of Th1-type cells across the blood-retina barrier in experimental autoimmune uveitis. J Leukocyte Biol (2006) 79(3):435–43. 10.1189/jlb.0305130 PubMed DOI

Liu Y-H, Mölzer C, Makinen K, Kamoi K, Corbett CLC, Klaska IP, et al. Treatment With FoxP3+ Antigen-Experienced T Regulatory Cells Arrests Progressive Retinal Damage in a Spontaneous Model of Uveitis. Front Immunol (2020) 11(2071). 10.3389/fimmu.2020.02071 PubMed DOI PMC

Ho JSY, Angel M, Ma Y, Sloan E, Wang G, Martinez-Romero C, et al. Hybrid gene origination creates human-virus chimeric proteins during infection. Cell (2020) 181(7):1502–17.e23. 10.1016/j.cell.2020.05.035 PubMed DOI PMC

Klein L, Robey EA, Hsieh C-S. Central CD4+ T cell tolerance: deletion versus regulatory T cell differentiation. Nat Rev Immunol (2019) 19(1):7–18. 10.1038/s41577-018-0083-6 PubMed DOI

Ye Z, Wu C, Zhang N, Du L, Cao Q, Huang X, et al. Altered gut microbiome composition in patients with Vogt-Koyanagi-Harada disease. Gut Microbes (2020) p:1–17. 10.1080/19490976.2019.1700754 PubMed DOI PMC

Wu H-J, Ivanov I, II, Darce J, Hattori K, Shima T, Umesaki Y, et al. Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity (2010) 32(6):815–27. 10.1016/j.immuni.2010.06.001 PubMed DOI PMC

Vivier E, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, et al. Innate Lymphoid Cells: 10 Years On. Cell (2018) 174(5):1054–66. 10.1016/j.cell.2018.07.017 PubMed DOI

Thaiss CA, Zmora N, Levy M, Elinav E. The microbiome and innate immunity. Nature (2016) 535(7610):65–74. 10.1038/nature18847 PubMed DOI

Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of Colonic Regulatory T Cells by Indigenous Clostridium Species. Science (2011) 331(6015):337. 10.1126/science.1198469 PubMed DOI PMC

Geuking MB, Cahenzli J, Lawson MAE, Ng DCK, Slack E, Hapfelmeier S, et al. Intestinal Bacterial Colonization Induces Mutualistic Regulatory T Cell Responses. Immunity (2011) 34(5):794–806. 10.1016/j.immuni.2011.03.021 PubMed DOI

Mosconi I, Geuking M, Zaiss M, Massacand J, Aschwanden C, Chung CK, et al. Intestinal bacteria induce TSLP to promote mutualistic T-cell responses. Mucosal Immunol (2013) 6(6):1157–67. 10.1038/mi.2013.12 PubMed DOI

Ohnmacht C, Park J-H, Cording S, Wing JB, Atarashi K, Obata Y, et al. The microbiota regulates type 2 immunity through RORγt+ T cells. Science (2015) 349(6251):989–93. 10.1126/science.aac4263 PubMed DOI

Sefik E, Geva-Zatorsky N, Oh S, Konnikova L, Zemmour D, McGuire AM, et al. Individual intestinal symbionts induce a distinct population of RORγ+ regulatory T cells. Science (2015) 349(6251):993–7. 10.1126/science.aaa9420 PubMed DOI PMC

Zhong Y, Cantwell A, Dube PHJ. Transforming Growth Factor β and CD25 Are Important for Controlling Systemic Dissemination following Yersinia enterocolitica Infection of the Gut. Infect Immun (2010) 78(9):3716–25. 10.1128/IAI.00203-10 PubMed DOI PMC

Sujino T, London M, Hoytema van Konijnenburg DP, Rendon T, Buch T, Silva HM, et al. Tissue adaptation of regulatory and intraepithelial CD4(+) T cells controls gut inflammation. Science (2016) 352(6293):1581–6. 10.1126/science.aaf3892 PubMed DOI PMC

Tong B, Yu J, Wang T, Dou Y, Wu X, Kong L, et al. Sinomenine suppresses collagen-induced arthritis by reciprocal modulation of regulatory T cells and Th17 cells in gut-associated lymphoid tissues. Mol Immunol (2015) 65(1):94–103. 10.1016/j.molimm.2015.01.014 PubMed DOI

Zeng H, Chi H. Metabolic control of regulatory T cell development and function. Trends Immunol (2015) 36(1):3–12. 10.1016/j.it.2014.08.003 PubMed DOI PMC

Zhao Q, Elson CO. Adaptive immune education by gut microbiota antigens. Immunology (2018) 154(1):28–37. 10.1111/imm.12896 PubMed DOI PMC

Gagliani N, Huber S. Basic aspects of T helper cell differentiation. T-Cell Differ (2017) 1514:19–30. 10.1007/978-1-4939-6548-9_2 PubMed DOI

Gagliani N, Vesely MCA, Iseppon A, Brockmann L, Xu H, Palm NW, et al. T H 17 cells transdifferentiate into regulatory T cells during resolution of inflammation. Nature (2015) 523(7559):221–5. 10.1038/nature14452 PubMed DOI PMC

Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, et al. Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature (2012) 482(7385):395–9. 10.1038/nature10772 PubMed DOI PMC

Panduro M, Benoist C, Mathis D. Tissue Tregs. Annu Rev Immunol (2016) 34:609–33. 10.1146/annurev-immunol-032712-095948 PubMed DOI PMC

Torres J, Hu J, Seki A, Eisele C, Nair N, Huang R, et al. Infants born to mothers with IBD present with altered gut microbiome that transfers abnormalities of the adaptive immune system to germ-free mice. Gut (2020) 69(1):42–51. 10.1136/gutjnl-2018-317855 PubMed DOI

Al Nabhani Z, Dulauroy S, Marques R, Cousu C, Al Bounny S, Déjardin F, et al. A weaning reaction to microbiota is required for resistance to immunopathologies in the adult. Immunity (2019) 50(5):1276–1288. e5. 10.1016/j.immuni.2019.02.014 PubMed DOI

Das G, Augustine MM, Das J, Bottomly K, Ray P, Ray A. An important regulatory role for CD4+ CD8αα T cells in the intestinal epithelial layer in the prevention of inflammatory bowel disease. Proc Natl Acad Sci (2003) 100(9):5324–9. 10.1073/pnas.0831037100 PubMed DOI PMC

Qiu Y, Peng K, Liu M, Xiao W, Yang H. CD8αα TCRαβ intraepithelial lymphocytes in the mouse gut. Digest Dis (2016) 61(6):1451–60. 10.1007/s10620-015-4016-y PubMed DOI

Goto Y, Panea C, Nakato G, Cebula A, Lee C, Diez MG, et al. Segmented filamentous bacteria antigens presented by intestinal dendritic cells drive mucosal Th17 cell differentiation. Immunity (2014) 40(4):594–607. 10.1016/j.immuni.2014.03.005 PubMed DOI PMC

Atarashi K, Tanoue T, Ando M, Kamada N, Nagano Y, Narushima S, et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell (2015) 163(2):367–80. 10.1016/j.cell.2015.08.058 PubMed DOI PMC

Bradley CP, Teng F, Felix KM, Sano T, Naskar D, Block KE, et al. Segmented filamentous bacteria provoke lung autoimmunity by inducing gut-lung axis Th17 cells expressing dual TCRs. Cell Host Microbe (2017) 22(5):697–704. e4. 10.1016/j.chom.2017.10.007 PubMed DOI PMC

Schuldt NJ, Auger JL, Spanier JA, Martinov T, Breed ER, Fife BT, et al. Cutting edge: Dual TCRα expression poses an autoimmune hazard by limiting regulatory T cell generation. J Immunol (2017) 199(1):33–8. 10.4049/jimmunol.1700406 PubMed DOI PMC

Sano Y, Ksander BR, Wayne SJ. Minor H, rather than MHC, alloantigens offer the greater barrier to successful orthotopic corneal transplantation in mice. Transplant Immunol (1996) 4(1):53–6. 10.1016/S0966-3274(96)80035-9 PubMed DOI

Haskova Z, Sproule TJ, Roopenian DC, Ksander BR. An immunodominant minor histocompatibility alloantigen that initiates corneal allograft rejection1. Transplantation (2003) 75(8):1368–74. 10.1097/01.TP.0000063708.26443.3B PubMed DOI

Vitova A, Kuffová L, Klaska IP, Holan V, Cornall RJ, Forrester JV. The high-risk corneal regraft model: a justification for tissue matching in humans. Transplant Int (2013) 26(4):453–61. 10.1111/tri.12055 PubMed DOI

Godlee F. Living with covid-19. BMJ (2020) 370:m3392. 10.1136/bmj.m3392 DOI

İnandıklıoğlu N, Akkoc T. Immune Responses to SARS-CoV, MERS-CoV and SARS-CoV-2. Cell Biol Trans Med (2020) 9:5–12. 10.1007/5584_2020_549 PubMed DOI

Sangith N. Unique fibrinogen-binding motifs in the nucleocapsid phosphoprotein of SARS CoV-2: Potential implications in host-pathogen interactions. Med Hypotheses (2020) 144:110030. 10.1016/j.mehy.2020.110030 PubMed DOI PMC

Abeler-Dorner L, Laing AG, Lorenc A, Ushakov DS, Clare S, Speak AO, et al. High-throughput phenotyping reveals expansive genetic and structural underpinnings of immune variation. Nat Immunol (2020) 21(1):86–100. 10.1038/s41590-019-0549-0 PubMed DOI PMC

Stoppelkamp S, Reid DM, Yeoh J, Taylor J, McKenzie EJ, Brown GD, et al. Murine pattern recognition receptor dectin-1 is essential in the development of experimental autoimmune uveoretinitis. Mol Immunol (2015) 67(2):398–406. 10.1016/j.molimm.2015.07.002 PubMed DOI

Brown B, Lee E, Snow P, Vance E, Iwakura Y, Ohno N, et al. Fungal-derived cues promote ocular autoimmunity through a Dectin-2/Card9-mediated mechanism. Clin Exp Immunol (2017) 190(3):293–303. 10.1111/cei.13021 PubMed DOI PMC

Lee EJ, Brown BR, Vance EE, Snow PE, Silver PB, Heinrichs D, et al. Mincle activation and the Syk/Card9 signaling axis are central to the development of autoimmune disease of the eye. J Immunol (2016) 196(7):3148–58. 10.4049/jimmunol.1502355 PubMed DOI PMC

Bing SJ, Shemesh I, Chong WP, Horai R, Jittayasothorn Y, Silver PB, et al. AS101 ameliorates experimental autoimmune uveitis by regulating Th1 and Th17 responses and inducing Treg cells. J Autoimmun (2019) 100:52–61. 10.1016/j.jaut.2019.02.006 PubMed DOI PMC

Wan C-K, He C, Sun L, Egwuagu CE, Leonard WJ. Cutting edge: IL-1 receptor signaling is critical for the development of autoimmune uveitis. J Immunol (2016) 196(2):543–6. 10.4049/jimmunol.1502080 PubMed DOI PMC

Huang X-F, Li Z, De Guzman E, Robinson P, Gensler L, Ward MM, et al. Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci. Invest Ophthalmol Visual Sci (2020) 61(6):3–3. 10.1167/iovs.61.6.3 PubMed DOI PMC

Nussenblatt RB, Mittal KK, Ryan S, Green WR, Maumenee AE. Birdshot retinochoroidopathy associated with HLA-A29 antigen and immune responsiveness to retinal S-antigen. Am J Ophthalmol (1982) 94(2):147–58. 10.1016/0002-9394(82)90069-1 PubMed DOI

Kuiper JJ, v Setten J, Devall M, Cretu-Stancu M, Hiddingh S, Ophoff RA, et al. Functionally distinct ERAP1 and ERAP2 are a hallmark of HLA-A29-(Birdshot) Uveitis. Hum Mol Genet (2018) 27(24):4333–43. 10.1101/338228 PubMed DOI PMC

Sugita S, Takase H, Kawaguchi T, Taguchi C, Mochizuki M. Cross-reaction between tyrosinase peptides and cytomegalovirus antigen by T cells from patients with Vogt-Koyanagi-Harada disease. Int Ophthalmol (2007) 27(2-3):87–95. 10.1007/s10792-006-9020-y PubMed DOI

Hou S, Kijlstra A, Yang P. Molecular genetic advances in uveitis. Prog Mol Biol Trans Sci (2015) 134:283–98. 10.1016/bs.pmbts.2015.04.009 PubMed DOI

Atan D, Turner SJ, Kilmartin DJ, Forrester JV, Bidwell J, Dick AD, et al. Cytokine gene polymorphism in sympathetic ophthalmia. Invest Ophthalmol Visual Sci (2005) 46(11):4245–50. 10.1167/iovs.05-0126 PubMed DOI

Atan D, Fraser-Bell S, Plskova J, Kuffova L, Hogan A, Tufail A, et al. Cytokine polymorphism in noninfectious uveitis. Invest Ophthalmol Visual Sci (2010) 51(8):4133–42. 10.1167/iovs.09-4583 PubMed DOI

Atan D, Fraser-Bell S, Plskova J, Kuffová L, Hogan A, Tufail A, et al. Punctate inner choroidopathy and multifocal choroiditis with panuveitis share haplotypic associations with IL10 and TNF loci. Invest Ophthalmol Visual Sci (2011) 52(6):3573–81. 10.1167/iovs.10-6743 PubMed DOI

Immig K, Gericke M, Menzel F, Merz F, Krueger M, Schiefenhövel F, et al. CD11c-positive cells from brain, spleen, lung, and liver exhibit site-specific immune phenotypes and plastically adapt to new environments. Glia (2015) 63(4):611–25. 10.1002/glia.22771 PubMed DOI

Rosenbaum JT, Lin P, Asquith M, The microbiome HLA. and the pathogenesis of uveitis. Japanese J Ophthalmol (2016) 60(1):1–6. 10.1007/s10384-015-0416-y PubMed DOI

Oezguen N, Yalcinkaya N, Kücükali C, Dahdouli M, Hollister E, Luna R, et al. Microbiota stratification identifies disease-specific alterations in neuro-Behçet’s disease and multiple sclerosis. Clin Exp Rheumatol (2019) 37(121):S58–66. PubMed

Silver PB, Horai R, Chen J, Jittayasothorn Y, Chan CC, Villasmil R, et al. Retina-specific T regulatory cells bring about resolution and maintain remission of autoimmune uveitis. J Immunol (2015) 194(7):3011–9. 10.4049/jimmunol.1402650 PubMed DOI PMC

Zhou R, Horai R, Silver PB, Mattapallil MJ, Zárate-Bladés CR, Chong WP, et al. The Living Eye “Disarms” Uncommitted Autoreactive T Cells by Converting Them to Foxp3&lt;sup<+&lt;/sup< Regulatory Cells following Local Antigen Recognition. J Immunol (2012) 188(4):1742. 10.4049/jimmunol.1102415 PubMed DOI PMC

Ito M, Komai K, Nakamura T, Srirat T, Yoshimura A. Tissue regulatory T cells and neural repair. Int Immunol (2019) 31(6):361–9. 10.1093/intimm/dxz031 PubMed DOI

Malviya M, Saoudi A, Bauer J, Fillatreau S, Liblau R. Treatment of experimental autoimmune encephalomyelitis with engineered bi-specific Foxp3+ regulatory CD4+ T cells. J Autoimmun (2020) 108:102401. 10.1016/j.jaut.2020.102401 PubMed DOI

O’Brien CA, Harris TH. ICOS-deficient and ICOS YF mutant mice fail to control Toxoplasma gondii infection of the brain. PloS One (2020) 15(1):e0228251. 10.1371/journal.pone.0228251 PubMed DOI PMC

Whibley N, Tucci A, Powrie F. Regulatory T cell adaptation in the intestine and skin. Nat Immunol (2019) 20(4):386–96. 10.1038/s41590-019-0351-z PubMed DOI

Iweala O, II, Nagler CR. Immune privilege in the gut: the establishment and maintenance of non-responsiveness to dietary antigens and commensal flora. Immunol Rev (2006) 213(1):82–100. 10.1111/j.1600-065X.2006.00431.x PubMed DOI

Kurashima Y, Kiyono H. Mucosal ecological network of epithelium and immune cells for gut homeostasis and tissue healing. Annu Rev Immunol (2017) 35:119–47. 10.1146/annurev-immunol-051116-052424 PubMed DOI

Li B, Selmi C, Tang R, Gershwin ME, Ma X. The microbiome and autoimmunity: a paradigm from the gut–liver axis. Cell Mol Immunol (2018) 15(6):595–609. 10.1038/cmi.2018.7 PubMed DOI PMC

Nakamura YK, Metea C, Karstens L, Asquith M, Gruner H, Moscibrocki C, et al. Gut Microbial Alterations Associated With Protection From Autoimmune Uveitis. Invest Ophthalmol Visusal Sci (2016) 57(8):3747–58. 10.1167/iovs.16-19733 PubMed DOI PMC

Janowitz C, Nakamura YK, Metea C, Gligor A, Yu W, Karstens L, et al. Disruption of Intestinal Homeostasis and Intestinal Microbiota During Experimental Autoimmune Uveitis. Invest Ophthalmol Visual Sci (2019) 60(1):420–9. 10.1167/iovs.18-24813 PubMed DOI PMC

Hegazy AN, West NR, Stubbington MJ, Wendt E, Suijker K, II, Datsi A, et al. Circulating and tissue-resident CD4+ T cells with reactivity to intestinal microbiota are abundant in healthy individuals and function is altered during inflammation. Gastroenterology (2017) 153(5):1320–37.e16. 10.1053/j.gastro.2017.07.047 PubMed DOI PMC

Mariño E, Richards JL, McLeod KH, Stanley D, Yap YA, Knight J, et al. Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol (2017) 18(5):552–62. 10.1038/ni.3713 PubMed DOI

Wu J-L, Zou J-Y, Hu E-D, Chen D-Z, Chen L, Lu F-B, et al. Sodium butyrate ameliorates S100/FCA-induced autoimmune hepatitis through regulation of intestinal tight junction and toll-like receptor 4 signaling pathway. Immunol Lett (2017) 190:169–76. 10.1016/j.imlet.2017.08.005 PubMed DOI

Gill P, Van Zelm M, Muir J, Gibson P. Short chain fatty acids as potential therapeutic agents in human gastrointestinal and inflammatory disorders. Aliment Pharmacol Ther (2018) 48(1):15–34. 10.1111/apt.14689 PubMed DOI

Hu E-D, Chen D-Z, Wu J-L, Lu F-B, Chen L, Zheng M-H, et al. High fiber dietary and sodium butyrate attenuate experimental autoimmune hepatitis through regulation of immune regulatory cells and intestinal barrier. Cell Immunol (2018) 328:24–32. 10.1016/j.cellimm.2018.03.003 PubMed DOI

Melbye P, Olsson A, Hansen TH, Søndergaard HB, Bang Oturai A. Short-chain fatty acids and gut microbiota in multiple sclerosis. Acta Neurologica Scand (2019) 139(3):208–19. 10.1111/ane.13045 PubMed DOI

Nakamura YK, Janowitz C, Metea C, Asquith M, Karstens L, Rosenbaum JT, et al. Short chain fatty acids ameliorate immune-mediated uveitis partially by altering migration of lymphocytes from the intestine. Sci Rep (2017) 7(1):11745. 10.1038/s41598-017-12163-3 PubMed DOI PMC

Erny D, Hrabě de Angelis AL, Jaitin D, Wieghofer P, Staszewski O, David E, et al. Host microbiota constantly control maturation and function of microglia in the CNS. Nat Neurosci (2015) 18(7):965–77. 10.1038/nn.4030 PubMed DOI PMC

Haghikia A, Jörg S, Duscha A, Berg J, Manzel A, Waschbisch A, et al. Dietary fatty acids directly impact central nervous system autoimmunity via the small intestine. Immunity (2015) 43(4):817–29. 10.1016/j.immuni.2015.09.007 PubMed DOI

Marungruang N, Arévalo Sureda E, Lefrançoise A, Weström B, Nyman M, Prykhodko O, et al. Impact of dietary induced precocious gut maturation on cecal microbiota and its relation to the blood-brain barrier during the postnatal period in rats. Neurogastroenterology (2018) 30(6):e13285. 10.1111/nmo.13285 PubMed DOI

Knox DL, Chen MF, Guilarte TR, Dang CV, Burnette J. Nutritional amblyopia. Folic acid, vitamin B-12, and other vitamins. Retina (1982) 2(4):288–93. 10.1097/00006982-198202040-00014 PubMed DOI

de Silva P, Jayamanne G, Bolton R. Folic acid deficiency optic neuropathy: A case report. J Med Case Rep (2008) 2(1):299. 10.1186/1752-1947-2-299 PubMed DOI PMC

Sen SK, Pukazhvanthen P, Abraham R. Plasma Homocysteine, Folate and Vitamin B(12) levels in senile cataract. Indian J Clin Biochem (2008) 23(3):255–7. 10.1007/s12291-008-0057-8 PubMed DOI PMC

Selhub J, Bagley LC, Miller J, Rosenberg IH, vitamins B. homocysteine, and neurocognitive function in the elderly. Am J Clin Nutr (2000) 71(2):614S–20S. 10.1093/ajcn/71.2.614s PubMed DOI

Bleich S, Kornhuber J, Junemann AG. Homocysteine in primary and secondary open-angle glaucoma. J Glaucoma (2003) 12(6):498–9; author reply 499. 10.1097/00061198-200312000-00013 PubMed DOI

Xu C, Wu Y, Liu G, Liu X, Wang F, Yu J. Relationship between homocysteine level and diabetic retinopathy: a systematic review and meta-analysis. Diagn Pathol (2014) 9:167. 10.1186/s13000-014-0167-y PubMed DOI PMC

Huang P, Wang F, Sah BK, Jiang J, Ni Z, Wang J, et al. Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis. Sci Rep (2015) 5:10585. 10.1038/srep10585 PubMed DOI PMC

Messedi M, Frigui M, Chaabouni K, Turki M, Neifer M, Lahiyani A, et al. Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and variations of homocysteine concentrations in patients with Behcet’s disease. Gene (2013) 527(1):306–10. 10.1016/j.gene.2013.06.041 PubMed DOI

Elbay AE, Topalkara A, Elbay A, Erdoğan H, Vural A, Bahadır Çetin A. Evaluation of Serum Homocysteine and Leptin Levels in Patients with Uveitis. Turkish J Ophthalmol (2015) 45(4):146–51. 10.4274/tjo.26539 PubMed DOI PMC

Sijilmassi O. Folic acid deficiency and vision: a review. Graefe’s Arch Clin Exp Ophthalmol (2019) 257(8):1573–80. 10.1007/s00417-019-04304-3 PubMed DOI

Elnakat H, Ratnam M. Distribution, functionality and gene regulation of folate receptor isoforms: implications in targeted therapy. Adv Drug Delivery Rev (2004) 56(8):1067–84. 10.1016/j.addr.2004.01.001 PubMed DOI

Zhao R, Qiu A, Tsai E, Jansen M, Akabas MH, Goldman ID. The Proton-Coupled Folate Transporter: Impact on Pemetrexed Transport and on Antifolates Activities Compared with the Reduced Folate Carrier. Mol Pharmacol (2008) 74(3):854. 10.1124/mol.108.045443 PubMed DOI PMC

Smith SB, Kekuda R, Gu X, Chancy C, Conway SJ, Ganapathy V. Expression of folate receptor alpha in the mammalian retinol pigmented epithelium and retina. Invest Ophthalmol Visual Sci (1999) 40(5):840–8. PubMed

Weitman SD, Weinberg AG, Coney LR, Zurawski VR, Jennings DS, Kamen BA. Cellular Localization of the Folate Receptor: Potential Role in Drug Toxicity and Folate Homeostasis. Cancer Res (1992) 52(23):6708. PubMed

Yamaguchi T, Hirota K, Nagahama K, Ohkawa K, Takahashi T, Nomura T, et al. Control of immune responses by antigen-specific regulatory T cells expressing the folate receptor. Immunity (2007) 27(1):145–59. 10.1016/j.immuni.2007.04.017 PubMed DOI

Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat Immunol (2007) 8(2):191–7. 10.1038/ni1428 PubMed DOI

Sakaguchi S, Yamaguchi T, Nomura T, Ono M. Regulatory T Cells and Immune Tolerance. Cell (2008) 133(5):775–87. 10.1016/j.cell.2008.05.009 PubMed DOI

Simpson TR, Li F, Montalvo-Ortiz W, Sepulveda MA, Bergerhoff K, Arce F, et al. Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma. J Exp Med (2013) 210(9):1695–710. 10.1084/jem.20130579 PubMed DOI PMC

Zamiri P, Sugita S, Streilein JW. Immunosuppressive properties of the pigmented epithelial cells and the subretinal space. Chem Immunol Allergy (2007) 92:86–93. 10.1159/000099259 PubMed DOI

Kalekar LA, Schmiel SE, Nandiwada SL, Lam WY, Barsness LO, Zhang N, et al. CD4(+) T cell anergy prevents autoimmunity and generates regulatory T cell precursors. Nat Immunol (2016) 17(3):304–14. 10.1038/ni.3331 PubMed DOI PMC

Chappert P, Schwartz RH. Induction of T cell anergy: integration of environmental cues and infectious tolerance. Curr Opin Immunol (2010) 22(5):552–9. 10.1016/j.coi.2010.08.005 PubMed DOI PMC

Mueller DL. Mechanisms maintaining peripheral tolerance. Nat Immunol (2010) 11(1):21–7. 10.1038/ni.1817 PubMed DOI

Martinez RJ, Zhang N, Thomas SR, Nandiwada SL, Jenkins MK, Binstadt BA, et al. Arthritogenic Self-Reactive CD4+ T Cells Acquire an FR4+CD73+ Anergic State in the Presence of Foxp3+ Regulatory T Cells. J Immunol (2012) 188(1):170. 10.4049/jimmunol.1101311 PubMed DOI PMC

Kalekar LA, Mueller DL. Relationship between CD4 Regulatory T Cells and Anergy In Vivo. J Immunol (2017) 198(7):2527–33. 10.4049/jimmunol.1602031 PubMed DOI PMC

Rossi M, Amaretti A, Raimondi S. Folate Production by Probiotic Bacteria. Nutrients (2011) 3(1):118–34. 10.3390/nu3010118 PubMed DOI PMC

Chen L, Gu Q, Li P, Chen S, Li Y. Genomic analysis of Lactobacillus reuteri WHH 1689 reveals its probiotic properties and stress resistance. Food Sci Nutr (2019) 7(2):844–57. 10.1002/fsn3.934 PubMed DOI PMC

Laiño JE, Levit R, d M de LeBlanc A, de Giori GS, LeBlanc JG. Characterization of folate production and probiotic potential of Streptococcus gallolyticus subsp. macedonicus CRL415. Food Microbiol (2019) 79:20–6. 10.1016/j.fm.2018.10.015 PubMed DOI

Cervantes-Barragan L, Chai JN, Tianero MD, Di Luccia B, Ahern PP, Merriman J, et al. Lactobacillus reuteri induces gut intraepithelial CD4+ CD8αα+ T cells. Science (2017) 357(6353):806–10. 10.1126/science.aah5825 PubMed DOI PMC

Lavelle A, Sokol H. Gut microbiota-derived metabolites as key actors in inflammatory bowel disease. Nat Rev Gastroentero (2020) p:1–15. 10.1038/s41575-019-0258-z PubMed DOI

Theuretzbacher U, Outterson K, Engel A, Karlén A. The global preclinical antibacterial pipeline. Nat Rev Microbiol (2019) 18(5):275–85. 10.1038/s41579-019-0288-0 PubMed DOI PMC

Sanders ME, Merenstein DJ, Reid G, Gibson GR, Rastall RA. Probiotics and prebiotics in intestinal health and disease: from biology to the clinic. Nat Rev Gastroentero (2019) 16(10):605–16. 10.1038/s41575-019-0173-3 PubMed DOI

Yeh Y-L, Lu M-C, Tsai B, Tzang B-S, Cheng S-M, Zhang X, et al. Heat-Killed Lactobacillus reuteri GMNL-263 Inhibits Systemic Lupus Erythematosus–Induced Cardiomyopathy in NZB/W F1 Mice. Probiotics Antimicrob Proteins (2020). 10.1007/s12602-020-09668-1 PubMed DOI

Calvo-Barreiro L, Eixarch H, Ponce-Alonso M, Castillo M, Lebrón-Galán R, Mestre L, et al. A Commercial Probiotic Induces Tolerogenic and Reduces Pathogenic Responses in Experimental Autoimmune Encephalomyelitis. Cells (2020) 9(4):906. 10.3390/cells9040906 PubMed DOI PMC

Rinaldi E, Consonni A, Cordiglieri C, Sacco G, Crasà C, Fontana A, et al. Therapeutic Effect of Bifidobacterium Administration on Experimental Autoimmune Myasthenia Gravis in Lewis Rats. Front Immunol (2019) 10:2949. 10.3389/fimmu.2019.02949 PubMed DOI PMC

Fitzgibbon G, Mills KH. The microbiota and immune-mediated diseases: Opportunities for therapeutic intervention. Eur J Immunol (2020) 50(3):326–37. 10.1002/eji.201948322 PubMed DOI

Lin P. Importance of the intestinal microbiota in ocular inflammatory diseases: A review. Clin Exp Ophthalmol (2019) 47(3):418–22. 10.1111/ceo.13493 PubMed DOI